MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

OHSU Knight Cancer Institute

Status: Invitation-only

Conditions: Breast Carcinoma

Treatments: Other: Training and Education; Other: Interview; Other: Electronic Health Record Review; Other: Media Intervention; Other: Survey Administration

Study type: Observational

Funder types: Other; Other U.S. Federal agency

Identifiers

NCT04996316

STUDY00022698 (Other Identifier)

NCI-2021-06583 (Registry Identifier)

R01HS027796 (U.S. AHRQ Grant/Contract)

Details and patient eligibility

About

This study collects information to implement MammoScreen for Breast Cancer Screening and Referrals. MammoScreen is a risk assessment questionnaire that identifies individuals at average and increased risk for breast cancer and guides their screening decisions.

Full description

PRIMARY OBJECTIVES:

I. Uptake of MammoScreen (the proportion of women who enroll and use MammoScreen, also referred to as Reach.

II. Identification of women with above-average risk for breast cancer by MammoScreen integrated with the electronic health record (EHR).

SECONDARY OUTCOMES:

I. Rates of mammography screening referral. II. Screening completed and mammography results stratified by risk category. III. Among those who meet criteria, genetic counseling referral, visit completed and genetic test done.

OUTLINE:

CLINICAL STAFF: During development some clinical team members will participate in usability testing (up to 30 minutes) of the electronic health record interface with MammoScreen. Some participants will undergo training sessions of about 20 minutes, then participate in interviews lasting up to 30 minutes at baseline prior to MammoScreen launch. Clinical staff also participate in interviews up to 30 minutes after MammoScreen launch during years 2-4. Participants complete surveys during the maintenance phase about six months after the last reminders are sent.

PATIENTS: Patients (enrolled from OHSU IMC) participate in interviews lasting up to 1 hour. Patients medical records are reviewed. Patients will be invited via MyChart to use the MammoScreen. Reminders will be sent via MyChart to non-respondents at 2 and 4 weeks. Patients will use MammoScreen one time right after enrollment. Some patients may also participate in interviews up to 1 hour each during years 3-5.

Enrollment: 1,141 estimated patients

Sex: Female

Ages: 40 to 74 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Women between the ages of 40 and 74
• Enrolled in MyChart
• Able to read English

Exclusion criteria

• Personal history of breast or ovarian cancer
• Currently Pregnant
• Currently in Hospice

Trial design

1,141 participants in 2 patient groups

Clinical staff (interview, training, survey)

Description:

Before implementation, some participants will complete usability testing of the interface in the electronic health record and MammoScreen. Participants undergo training sessions over 20 minutes and participate in interviews over 30 minutes at baseline, prior to MammoScreen launch. Clinical staff also participate in interviews over 30 minutes after MammoScreen launch during years 2-4. Participants complete surveys during the maintenance phase, about six months after the last reminders are sent.

Treatment:

Other: Survey Administration

Other: Electronic Health Record Review

Other: Interview

Other: Training and Education

Patients (interview, MammoScreen)

Description:

Patients participate in interviews up to 1 hour. Patients medical records are reviewed. Patients use the MammoScreen at enrollment. Some Patients will also participate in interviews up to 1 hour, each during years 3-5.

Treatment:

Other: Media Intervention

Other: Electronic Health Record Review

Other: Interview